Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 3.143% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=C(/C=C/NCC(=O)c1ccccc1)c1ccc(Br)cc1
b CCC(C)[C@H](NC(=O)NCc1ccc(S(N)(=O)=O)cc1)C(=O)OC
c N#Cc1ccc(C(=O)NCC(c2ccco2)N2CCCCC2)cc1
Answer: b. CCC(C)[C@H](NC(=O)NCc1ccc(S(N)(=O)=O)cc1)C(=O)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)[C@H](NC(=O)NCc1ccc(S(N)(=O)=O)cc1)C(=O)OC
CCC(C)[C@H](NC(=O)NCc1ccc(S(N)(=O)=O)cc1)C(=O)OC
methyl (2S)-3-methyl-2-[(4-sulfamoylphenyl)methylcarbamoylamino]pentanoate